Semaglutide is a peptide in the GLP-1 receptor agonist class, studied in metabolic research. In the research market it is supplied as a reference compound for research use only, not as the approved medical product.
What class it belongs to
Semaglutide is part of a family of peptides known as GLP-1 receptor agonists. As a single agonist, it is designed to interact with one target, the GLP-1 receptor, which is why it is often used as a reference point when comparing newer multi-target compounds.
How it is studied
In the laboratory, Semaglutide is studied in metabolic research. As with any research peptide, the research-grade compound is a study tool, not a therapeutic, and it is supplied for research use only.
Browse research-grade peptides
Every Axis compound is third-party tested to 99.4%+ purity, with a certificate of analysis on every batch.
What to look for
Because peptide identity and purity cannot be judged by eye, a research-grade compound should ship with a batch-specific certificate of analysis. For how it compares to a dual agonist, see Semaglutide vs. Tirzepatide.
Key takeaways
- Semaglutide is a GLP-1 receptor agonist peptide.
- It is a single agonist, targeting the GLP-1 receptor.
- It is studied in metabolic research.
- Research-grade Semaglutide is supplied for research use only.
A note on research use
The peptides supplied by Axis Peptide Labs are reference compounds for laboratory and research use only. They are intended for qualified researchers working in academic, institutional, and analytical settings. They are not drugs, foods, cosmetics, or medical products, and they are not intended for human or veterinary consumption. Documented identity and documented purity are what matter most when sourcing a compound, both of which are published on the Axis certificates of analysis page.
